SEQUESSOME TECH HOLDINGS LIMITED has a total of 23 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ITALMED S R L, GATTEFOSSE HOLDING and CLJI IP COMPANY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Israel | 3 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | Hong Kong | 2 | |
#8 | Mexico | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Henry William | 12 |
#2 | Garraway Richard Wolf | 12 |
#3 | Richard Wolf Garraway | 5 |
#4 | William Henry | 4 |
#5 | Vierl Ulrich | 2 |
#6 | Rother Matthias | 2 |
#7 | Iliffe George Langton | 2 |
#8 | Mayo John Charles | 2 |
#9 | Earl Michael | 1 |
#10 | Nicholas Baverstock | 1 |
Publication | Filing date | Title |
---|---|---|
MX2018000024A | Blended formulations. | |
EA029132B1 | Vesicular formulations for the treatment of pain associated with osteoarthritis |